Microbiome-targeted Diet Therapy in Ulcerative Colitis

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Minnesota

About this trial

The central objective of this proposal is to test a novel diet capable of meeting the elevated protein requirements in ulcerative colitis (UC), while simultaneously decreasing microbial hydrogen sulfide (H2S) production in the colon with fiber.

Eligibility criteria

Qualifiers

Ability and willingness to provide informed consent

Age at least 18 years old

Diagnosis of UC based on clinical and endoscopic criteria

UC duration of at least 3 months

Disqualifiers

Moderate or severe UC as defined by UCEIS ≥5

History of stomach surgery or bowel resection

Antibiotic use within 3 months

Anticipated antibiotic exposure during the study period (e.g. perioperative antibiotics)

Trial design

Treatments tested in this trial

  • High Protein, High Fiber (HPHF) Diet

Treatment groups

40 Participants
are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators